Pfizer
PFE
PFE
2,794 hedge funds and large institutions have $160B invested in Pfizer in 2021 Q3 according to their latest regulatory filings, with 192 funds opening new positions, 1,214 increasing their positions, 1,115 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more call options, than puts
Call options by funds: $3.51B | Put options by funds: $3.19B
9% more repeat investments, than reductions
Existing positions increased: 1,214 | Existing positions reduced: 1,115
0.06% less ownership
Funds ownership: 66.31% → 66.25% (-0.06%)
Holders
2,794
Holding in Top 10
105
Calls
$3.51B
Puts
$3.19B
Top Buyers
| 1 | +$641M | |
| 2 | +$442M | |
| 3 | +$355M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$329M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$248M |
Top Sellers
| 1 | -$893M | |
| 2 | -$757M | |
| 3 | -$632M | |
| 4 |
Two Sigma Advisers
New York
|
-$421M |
| 5 |
JP Morgan Chase
New York
|
-$336M |